SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

12.25p
   
  • Change Today:
    -0.38p
  • 52 Week High: 26.10p
  • 52 Week Low: 12.04p
  • Currency: UK Pounds
  • Shares Issued: 258.78m
  • Volume: 3,281,220
  • Market Cap: £31.70m

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -24.2% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 6.8 n/a
Pr/Book 3.4  
Latest F'cast
Revenue 283.7% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

SBTX Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-21 n/a (1.50) (0.01)p n/a n/a n/a n/a 0.0%
30-Jun-22 0.07 (2.99) (1.78)p n/a n/a n/a n/a 0.0%
30-Jun-23 0.13 (3.01) (1.72)p n/a n/a n/a n/a 0.0%
30-Jun-24 1.21 (2.95) (1.54)p n/a n/a n/a n/a 0.0%
30-Jun-25 4.64 (0.72) (0.31)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SBTX Company Announcements

Holding(s) in Company 08-Dec-2025 14:31 RNS
Posting of Annual Report and AGM Notice 08-Dec-2025 07:00 RNS
Final Results 05-Dec-2025 07:00 RNS

SBTX ShareCast News

SkinBioTherapeutics revenue rises fourfold, stil... 14-Aug-2025 ShareCast
SkinBioTherapeutics inks Superdrug deal, raises ... 16-Jun-2025 ShareCast
SkinBioTherapeutics shares jump on acquisition o... 11-Oct-2024 ShareCast

Latest SBTX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

SBTX Market Data

Currency UK Pounds
Share Price 12.25p
Change Today -0.38p
% Change -2.97 %
52 Week High 26.10p
52 Week Low 12.04p
Volume 3,281,220
Shares Issued 258.78m
Market Cap £31.70m

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average
75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average
Price Trend
36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Income Not Available
Growth
49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average
72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average

SBTX Dividends

No dividends found

Trades for 09-Dec-2025

Time Volume / Share Price
16:36 250,000 @ 12.32p
17:09 9,000 @ 12.25p
16:24 21,098 @ 12.40p
16:23 21,200 @ 12.40p
16:05 4,530 @ 12.21p

SBTX Key Personnel

CEO Stuart Ashman

Top of Page